BioNTech Bags Bargain With Neon Buy
Expands Cell Therapy Pipeline
Neon listed on the NASDAQ at $16 per share 18 months ago. It has now been picked up by the ambitious German biotech for just $2.18 per share, having recently ended its cancer vaccine programs and laid off a quarter of its workforce.
